Pictet Asset Management (UK)’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $5.36M | Buy |
134,324
+85,324
| +174% | +$3.4M | 0.01% | 826 |
|
|
2021
Q1 | $2.2M | Sell |
49,000
-7,000
| -13% | -$315K | ﹤0.01% | 963 |
|
|
2020
Q4 | $3.17M | Buy |
56,000
+7,100
| +15% | +$401K | ﹤0.01% | 890 |
|
|
2020
Q3 | $2.32M | Sell |
48,900
-2,000
| -4% | -$94.9K | ﹤0.01% | 873 |
|
|
2020
Q2 | $3M | Buy |
50,900
+1,200
| +2% | +$70.8K | 0.01% | 801 |
|
|
2020
Q1 | $2.35M | Buy |
49,700
+3,500
| +8% | +$165K | 0.01% | 819 |
|
|
2019
Q4 | $2.79M | Sell |
46,200
-111,800
| -71% | -$6.75M | ﹤0.01% | 859 |
|
|
2019
Q3 | $9.47M | Buy |
158,000
+7,500
| +5% | +$449K | 0.02% | 528 |
|
|
2019
Q2 | $9.67M | Buy |
150,500
+67,600
| +82% | +$4.34M | 0.02% | 523 |
|
|
2019
Q1 | $6.73M | Buy |
82,900
+28,300
| +52% | +$2.3M | 0.01% | 616 |
|
|
2018
Q4 | $2.95K | Buy |
54,600
+15,700
| +40% | +$849 | 0.01% | 757 |
|
|
2018
Q3 | $2.01M | Hold |
38,900
| – | – | ﹤0.01% | 876 |
|
|
2018
Q2 | $1.62M | Buy |
+38,900
| New | +$1.62M | ﹤0.01% | 817 |
|
|
2016
Q3 | – | Sell |
-75,628
| Closed | -$1.72M | – | 839 |
|
|
2016
Q2 | $1.72M | Buy |
75,628
+1,828
| +2% | +$41.5K | 0.01% | 755 |
|
|
2016
Q1 | $2.55M | Buy |
73,800
+32,600
| +79% | +$1.13M | 0.01% | 656 |
|
|
2015
Q4 | $2.55M | Sell |
41,200
-4,400
| -10% | -$273K | 0.01% | 689 |
|
|
2015
Q3 | $1.84M | Sell |
45,600
-116,200
| -72% | -$4.7M | 0.01% | 733 |
|
|
2015
Q2 | $8.89M | Buy |
161,800
+100,906
| +166% | +$5.54M | 0.04% | 447 |
|
|
2015
Q1 | $3.45M | Buy |
60,894
+45,315
| +291% | +$2.57M | 0.01% | 662 |
|
|
2014
Q4 | $962K | Buy |
+15,579
| New | +$962K | ﹤0.01% | 805 |
|
|
2014
Q2 | – | Sell |
-52,700
| Closed | -$2.28M | – | 880 |
|
|
2014
Q1 | $2.28M | Sell |
52,700
-31,400
| -37% | -$1.36M | 0.01% | 723 |
|
|
2013
Q4 | $3.35M | Buy |
84,100
+63,400
| +306% | +$2.53M | 0.02% | 623 |
|
|
2013
Q3 | $777K | Buy |
+20,700
| New | +$777K | ﹤0.01% | 788 |
|